| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | 0.054 | 0.1 |
| mRNA | piperlongumine | CTRPv2 | pan-cancer | AAC | -0.05 | 0.1 |
| mRNA | SZ4TA2 | CTRPv2 | pan-cancer | AAC | -0.082 | 0.1 |
| mRNA | FQI-2 | CTRPv2 | pan-cancer | AAC | -0.05 | 0.1 |
| mRNA | Repligen 136 | CTRPv2 | pan-cancer | AAC | 0.057 | 0.1 |
| mRNA | ABT-737 | CTRPv2 | pan-cancer | AAC | -0.056 | 0.1 |
| mRNA | thalidomide | CTRPv2 | pan-cancer | AAC | -0.081 | 0.1 |
| mRNA | niclosamide | CTRPv2 | pan-cancer | AAC | -0.055 | 0.1 |
| mRNA | Docetaxel | CTRPv2 | pan-cancer | AAC | -0.072 | 0.1 |
| mRNA | ML239 | CTRPv2 | pan-cancer | AAC | -0.054 | 0.1 |